0000899243-23-001064.txt : 20230105 0000899243-23-001064.hdr.sgml : 20230105 20230105194914 ACCESSION NUMBER: 0000899243-23-001064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brennan Nora CENTRAL INDEX KEY: 0001790215 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 23513214 MAIL ADDRESS: STREET 1: C/O TELA BIO, INC. STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 24 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-03 0 0000831547 SPECTRUM PHARMACEUTICALS INC SPPI 0001790215 Brennan Nora 2 ATLANTIC AVENUE, 6TH FLOOR BOSTON MA 02110 0 1 0 0 See Remarks Common Stock, $0.001 par value 2023-01-03 4 A 0 240000 0.00 A 600215 D Stock Option (Right to Buy) 0.38 2023-01-03 4 A 0 840000 0.00 A 2033-01-03 Common Stock 840000 840000 D One third of the aggregate amount of restricted stock units shall vest on each of January 3, 2024, 2025 and 2026, respectively. One third of the aggregate amount of option shares shall vest on each of January 3, 2024, 2025 and 2026, respectively. Executive Vice President and Chief Financial Officer /s/ Keith M. McGahan, Attorney-in-Fact for Nora E. Brennan 2023-01-05